Parkworth Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$4.19K Buy
15
+7
+88% +$1.98K ﹤0.01% 185
2025
Q1
$2.49K Sell
8
-13
-62% -$3.84K ﹤0.01% 168
2024
Q4
$5.56K Buy
+21
New +$6.23K ﹤0.01% 160

Other funds holding AMGN

Parkworth Wealth Management's AMGN Position: Q2 2025 in Review

Parkworth Wealth Management increased its Amgen (AMGN) stake by 88% in Q2 2025, buying an estimated $1.98K and bringing the position to 15 shares worth $4.19K. The position accounts for ﹤0.01% of the portfolio, ranked #185.

Parkworth Wealth Management first reported a position in AMGN in Q4 2024 and has held it in 3 quarters since. The position peaked at $5.56K in Q4 2024. 2,851 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.

  • Parkworth Wealth Management held 15 shares of Amgen worth $4.19K as of Q2 2025.
  • Parkworth Wealth Management bought 7 Amgen shares in Q2 2025, an estimated $1.98K.
  • Amgen made up ﹤0.01% of Parkworth Wealth Management's portfolio in Q2 2025, its #185 holding.
  • Parkworth Wealth Management first reported a position in Amgen in Q4 2024 and has held it in 3 quarters since.
  • Parkworth Wealth Management's Amgen position peaked at $5.56K in Q4 2024.
  • 2,851 funds tracked by Wall St. Rank held Amgen as of Q2 2025.

Based on Parkworth Wealth Management's 13F filing for Q2 2025, filed 13 Aug 2025.